Natarajan Sethuraman, PhD, Elevated to President of R&D at Entrada Therapeutics

BOSTON, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. TRDA, a forward-thinking clinical-stage biopharmaceutical company, proudly announced the promotion of Dr. Natarajan Sethuraman to President of Research and Development. Dr. Sethuraman, a seasoned veteran in the industry, has been instrumental in propelling Entrada Therapeutics toward its mission of innovating and delivering ground-breaking medicines. With a focus on intracellular Endosomal Escape Vehicle (EEV™) therapies, Entrada Therapeutics is at the forefront of creating a novel class of medicinal treatments aimed at enhancing the lives of patients on a global scale. The company's dedication to research and development under the new leadership is expected to usher in a transformative era for intracellular therapeutic solutions.

Exploring the Significance of EEV™ Therapeutics

The biopharmaceutical sector has been on a quest to navigate the complex interior landscape of human cells. Entrada Therapeutics is leading this charge with its proprietary EEV™ platform. The technology facilitates the delivery of therapeutic agents directly to the intracellular environment, effectively escaping the endosomal pathway which often hinders treatment efficacy. This advancement has the potential to revolutionize the treatment paradigms for a plethora of diseases that were previously deemed difficult to address using conventional methods.

Dr. Sethuraman's Vision for the Future

Dr. Natarajan Sethuraman brings a wealth of knowledge and a proven track record to his new role as President of Research and Development. His expertise and strategic vision will continue to be a driving force behind Entrada Therapeutics' research endeavors. His leadership is expected to amplify the company's research capabilities and accelerate the development of EEV™ therapies, moving closer to the goal of providing innovative and effective solutions for patients in need.

biopharmaceutical, leadership, innovation